
Stanford Regenerates Knee Cartilage, Paving Way for Arthritis Treatment
Stanford researchers block the aging-related gerozyme 15-PGDH with an injectable (and now an oral drug in trials), triggering cartilage regeneration in mouse knee joints and human tissue samples, reversing age-related cartilage loss and showing promise for preventing arthritis after knee injuries.













